Real-time enrollment status for this nodal marginal zone lymphoma clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 5:48 AM UTC
| NCT Number | NCT05700149 |
| Recruiting Status | Recruiting |
| Condition | Nodal Marginal Zone Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 4 sites in the US |
| Sponsor | International Extranodal Lymphoma Study Group (IELSG) |
| Last Updated on CT.gov | June 22, 2026 (Jun 22, 2026) |
As of September 2, 2026: Clinical trial NCT05700149 is currently recruiting participants. This clinical trial study for nodal marginal zone lymphoma is actively seeking new participants at 4 locations across the United States. The study is sponsored by International Extranodal Lymphoma Study Group (IELSG). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05700149 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05700149 was last updated Jun 22, 2026 (June 22, 2026). HelloStudys verifies this status automatically.